Systemic therapy landscape of advanced prostate cancer.
Paul AK, Melson JW, Hirani S, Muthusamy S.
Adv Cancer Res. 2024;161:367-402. doi: 10.1016/bs.acr.2024.04.004. Epub 2024 Apr 27.
Optimizing CAR-T cell therapy for solid tumors: current challenges and potential strategies.
Ai K, Liu B, Chen X, Huang C, Yang L, Zhang W, Weng J, Du X, Wu K, Lai P.
J Hematol Oncol. 2024 Nov 5;17(1):105. doi: 10.1186/s13045-024-01625-7.
The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol.
Banu MA, Raza SM, Amini M, Seaman S, Rubino F, Snyder R, Patel S, DeMonte F, Conley AP.
Neurosurg Focus. 2024 May;56(5):E15. doi: 10.3171/2024.2.FOCUS2416.
In vivo chimeric antigen receptor (CAR)-T cell therapy.
Bot A, Scharenberg A, Friedman K, Guey L, Hofmeister R, Andorko JI, Klichinsky M, Neumann F, Shah JV, Swayer AJ, Trudeau K, Weissman D, Stephan MT, Buchholz CJ, June CH.
Nat Rev Drug Discov. 2026 Feb;25(2):116-137. doi: 10.1038/s41573-025-01291-5. Epub 2025 Sep 30.
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
Davis DMR, Drucker AM, Alikhan A, Bercovitch L, Cohen DE, Darr JM, Eichenfield LF, Frazer-Green L, Paller AS, Schwarzenberger K, Silverberg JI, Singh AM, Wu PA, Sidbury R.
J Am Acad Dermatol. 2024 Feb;90(2):e43-e56. doi: 10.1016/j.jaad.2023.08.102. Epub 2023 Nov 7.
Treatment of Advanced Prostate Cancer.
Teo MY, Rathkopf DE, Kantoff P.
Annu Rev Med. 2019 Jan 27;70:479-499. doi: 10.1146/annurev-med-051517-011947.
Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases.
Das S, Berlin J.
Surg Oncol Clin N Am. 2021 Jan;30(1):189-204. doi: 10.1016/j.soc.2020.08.008. Epub 2020 Oct 28.
Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
D'Andrea MA, Reddy GK.
Am J Clin Oncol. 2020 Mar;43(3):218-228. doi: 10.1097/COC.0000000000000651.
Evolving therapeutic landscape of advanced hepatocellular carcinoma.
Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C.
Nat Rev Gastroenterol Hepatol. 2023 Apr;20(4):203-222. doi: 10.1038/s41575-022-00704-9. Epub 2022 Nov 11.
First-line systemic therapy and sequencing options in advanced biliary tract cancer: A systematic review and network meta-analysis.
Xu R, Zhou J, Yang J, Yu Y, Wang H, Zhang Z, Yang J, Zhang G, Liao R.
Biosci Trends. 2025 Jan 14;18(6):555-562. doi: 10.5582/bst.2024.01376. Epub 2024 Dec 8.
